NEWTON-2 cisternal (Nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage): A phase 2, multicenter, randomized, open-label safety study of intracisternal EG-1962 in aneurysmal subarachnoid hemorrhage

  • R. Loch Macdonald
  • , Daniel Hänggi
  • , Nerissa U. Ko
  • , Tim E. Darsaut
  • , Andrew P. Carlson
  • , George K. Wong
  • , Nima Etminan
  • , Stephan A. Mayer
  • , E. Francois Aldrich
  • , Michael N. Diringer
  • , David Ng
  • , Poul Strange
  • , Thomas Bleck
  • , Robert Grubb
  • , Jose I. Suarez

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Fingerprint

Dive into the research topics of 'NEWTON-2 cisternal (Nimodipine microparticles to enhance recovery while reducing toxicity after subarachnoid hemorrhage): A phase 2, multicenter, randomized, open-label safety study of intracisternal EG-1962 in aneurysmal subarachnoid hemorrhage'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Neuroscience